XML 38 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share Based Payments (Tables)
3 Months Ended
May 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions used to Calculate Fair Value of Options on Date of Grant
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant during the three months ended May 31, 2013 and 2014:
 
 
Three Months Ended May 31,
 
2013
 
2014
Risk-Free Interest Rate:
0.6%
 
1.2% - 1.3%
Expected Dividend Yield:
0%
 
0%
Expected Life (Years):
4.3
 
4.3
Expected Volatility:
115.9%
 
72.5% - 73.9%
Summary of Stock Options Outstanding and Activity
The following table presents a summary of the Company’s stock options outstanding at May 31, 2014, and stock option activity during the three months ended May 31, 2014 (“Price” reflects the weighted average exercise price per share):
 
 
Options
 
Price
 
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
Outstanding, beginning of period
6,984,605

 
$
3.74

 
 
 
 
Granted
215,000

 
3.24

 
 
 
 
Exercised (1)
533,044

 
0.52

 
 
 
 
Forfeited
10,000

 
0.70

 
 
 
 
Expired
986,610

 
17.45

 
 
 
 
Outstanding, end of period
5,669,951

 
1.65

 
7.1
 
$
8,447

Exercisable, end of period
2,701,971

 
1.83

 
5.8
 
$
4,356


(1) 
Summary of Nonvested Options and Changes
A summary of the Company’s nonvested options at May 31, 2014, and changes during the three months ended May 31, 2014, is presented below:
 
 
Options
 
Weighted Average
Grant Date
Fair Value
Nonvested, beginning of period
3,325,481

 
$
0.98

Granted
215,000

 
1.84

Vested
562,501

 
0.94

Forfeited
10,000

 
0.57

Nonvested, end of period
2,967,980

 
1.05

Summary of Restricted Stock Grants Outstanding and Activity
The following table presents a summary of the Company’s restricted stock grants outstanding at May 31, 2014, and restricted stock activity during the three months ended May 31, 2014 (“Price” reflects the weighted average share price at the date of grant):
 
 
Awards
 
Price
Grants outstanding, beginning of period
590,544

 
$
1.79

Granted
1,205,848

 
3.33

Vested (restriction lapsed)
1,150,848

 
3.12

Grants outstanding, end of period
645,544

 
2.30

Stock-Based Compensation Expense and Related Tax Benefits Recognized
The following table summarizes stock-based compensation expense and related tax benefits recognized by the Company during the three ended May 31, 2013 and 2014:
 
 
Three Months Ended May 31,
 
2013
 
2014
Station operating expenses
$
253

 
$
402

Corporate expenses
410

 
546

Stock-based compensation expense included in operating expenses
663

 
948

Tax benefit

 
331

Recognized stock-based compensation expense, net of tax
$
663

 
$
617